NeutraKine® Thrombin-Coagulation FactorII Monoclonal antibody
NeutraKine® Thrombin-Coagulation FactorII Monoclonal Antibody for Neutralization, ELISA
Host / Isotype
Mouse / IgG1
Reactivity
human
Applications
Neutralization, ELISA
Conjugate
Unconjugated
CloneNo.
2G3G10
验证数据展示
Neutralization |
产品信息
69014-1-Ig targets NeutraKine® Thrombin-Coagulation FactorII in Neutralization, ELISA applications and shows reactivity with human samples.
Tested Applications | Neutralization, ELISA Application Description |
Tested Reactivity | human |
Immunogen | human Humankine Thrombin-Coagulation FactorII protein HZ-3010 种属同源性预测 |
Host / Isotype | Mouse / IgG1 |
Class | Monoclonal |
Type | Antibody |
Full Name | coagulation factor II (prothrombin) |
Synonyms | Coagulation factor II, F2, EC:3.4.21.5, Activation peptide fragment 2, Activation peptide fragment 1 |
Gene Symbol | F2 |
Gene ID (NCBI) | 2147 |
RRID | AB_2882932 |
Conjugate | Unconjugated |
Form | Lyophilized Powder |
Purification Method | Protein G purification |
Storage Buffer | Sterile PBS. |
Endotoxin | <0.1 EU/μg |
Reconstitution | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
Stability and Storage | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
背景介绍
Normal blood coagulation is a complex process, involving a cascade of activation of different plasma proteins, ultimately resulting in the formation of a clot, called fibrin. Coagulation Factor II, also known as prothrombin or factor II, is one of the components of this chain of plasma proteins involved in blood coagulation. Prothrombin is the precursor of thrombin, which is essential in the processes of hemostasis and thrombosis.
This antibody can be used to neutralize the bioactivity of Thrombin-Coagulation FactorII.
This antibody can be used to neutralize the bioactivity of Thrombin-Coagulation FactorII.